Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
There is no characterised dose-response curve for adverse effects
For research transport, carry three documents in hard copy: (1) a letter of authorization from your sponsoring institution on official letterhead specifying the compound name, quantity, and research purpose
This is a third-generation LH-RH antagonist, developed by Ferring Pharmaceuticals for use in prostate cancer in the last decade and approved by the FDA for the treatment of prostate cancer 25
However, this does not explain why human tissues better retain methylcobalamin, making it more effective than cyanocobalamin in increasing active B12 levels [110]
US$ 25.02
US$ 22.91
US$ 27.56
US$ 23.77
US$ 26.82
